Vanguard Group’s NPS Pharmaceuticals NPSP Stock Holding History
Bought
Maintained
Sold
Other funds holding NPSP
Vanguard Group's NPSP Position: Q1 2015 in Review
Vanguard Group sold out of NPS Pharmaceuticals (NPSP) in Q1 2015, closing a stake of 5,965,074 shares — an estimated $213M sold.
Vanguard Group first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $213M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.
- Vanguard Group reported no remaining NPS Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- Vanguard Group sold 5,965,074 NPS Pharmaceuticals shares in Q1 2015, an estimated $213M.
- Vanguard Group first reported a position in NPS Pharmaceuticals in Q2 2013 and held it in 7 quarters.
- Vanguard Group's NPS Pharmaceuticals position peaked at $213M in Q4 2014.
- 1 fund tracked by Wall St. Rank held NPS Pharmaceuticals as of Q1 2015.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.